TreeWAS – Variant ID: rs8098600

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T39.1 4-Aminophenol derivatives	0.000	0.985	0.015
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.000	0.987	0.013
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.988	0.012
K51 Ulcerative colitis	0.012	0.988	0.000
K51.4 Pseudopolyposis of colon	0.012	0.988	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.988	0.012
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.988	0.012
K51.9 Ulcerative colitis, unspecified	0.012	0.988	0.000
K51.3 Ulcerative (chronic) rectosigmoiditis	0.011	0.989	0.000
K51.8 Other ulcerative colitis	0.011	0.989	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.989	0.011
M53.38 Sacrococcygeal disorders, not elsewhere classified-Sacral/s	0.000	0.989	0.011
T42.1 Iminostilbenes	0.000	0.989	0.011
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.990	0.010
K51.5 Mucosal proctocolitis	0.010	0.990	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.990	0.010
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.990	0.010
T42.4 Benzodiazepines	0.000	0.990	0.010
F31.9 Bipolar affective disorder, unspecified	0.000	0.990	0.010
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.990	0.010
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.990	0.010
K51.0 Ulcerative (chronic) enterocolitis	0.010	0.990	0.000
Z85.6 Personal history of leukaemia	0.000	0.991	0.009
K51.1 Ulcerative (chronic) ileocolitis	0.009	0.991	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.991	0.009
F31 Bipolar affective disorder	0.000	0.991	0.009
T46.1 Calcium-channel blockers	0.000	0.991	0.009
T39.4 Antirheumatics, not elsewhere classified	0.000	0.991	0.009
T39.2 Pyrazolone derivatives	0.000	0.991	0.009
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.991	0.009
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.991	0.009
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.991	0.009
T40.4 Other synthetic narcotics	0.000	0.991	0.009
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.991	0.009
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.991	0.009
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.991	0.009
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.991	0.009
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.991	0.009
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.991	0.009
S06.6 Traumatic subarachnoid haemorrhage	0.000	0.991	0.009
T42.0 Hydantoin derivatives	0.000	0.991	0.009
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.991	0.009
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.991	0.009
T42.3 Barbiturates	0.000	0.991	0.009
T42.2 Succinimides and oxazolidinediones	0.000	0.991	0.009
T40.2 Other opioids	0.000	0.991	0.009
T43.2 Other and unspecified antidepressants	0.000	0.992	0.008
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.000	0.992	0.008
F31.6 Bipolar affective disorder, current episode mixed	0.000	0.992	0.008
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.992	0.008
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.992	0.008
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.992	0.008
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.992	0.008
T46.7 Peripheral vasodilators	0.000	0.992	0.008
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.992	0.008
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.992	0.008
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.992	0.008
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.992	0.008
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.992	0.008
F31.0 Bipolar affective disorder, current episode hypomanic	0.000	0.992	0.008
T36 Poisoning by systemic antibiotics	0.000	0.992	0.008
K51.2 Ulcerative (chronic) proctitis	0.008	0.992	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.992	0.008
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.992	0.008
T40.8 Lysergide [LSD]	0.000	0.992	0.008
T40.7 Cannabis (derivatives)	0.000	0.992	0.008
T40.5 Cocaine	0.000	0.992	0.008
T40.3 Methadone	0.000	0.992	0.008
T40.1 Heroin	0.000	0.992	0.008
T40.0 Opium	0.000	0.992	0.008
T50.8 Diagnostic agents	0.000	0.992	0.007
T50.7 Analeptics and opioid receptor antagonists	0.000	0.992	0.007
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.992	0.007
T50.5 Appetite depressants	0.000	0.992	0.007
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.992	0.007
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.992	0.007
T50.1 Loop [high-ceiling] diuretics	0.000	0.992	0.007
T50.0 Mineralocorticoids and their antagonists	0.000	0.992	0.007
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.992	0.007
F33.9 Recurrent depressive disorder, unspecified	0.000	0.993	0.007
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.993	0.007
F31.7 Bipolar affective disorder, currently in remission	0.000	0.993	0.007
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.993	0.007
T43.9 Psychotropic drug, unspecified	0.000	0.993	0.007
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.993	0.007
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.993	0.007
N04.9 Unspecified	0.007	0.993	0.000
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.000	0.993	0.007
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.993	0.007
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.993	0.007
F31.8 Other bipolar affective disorders	0.000	0.993	0.007
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.000	0.993	0.007
T45.0 Antiallergic and antiemetic drugs	0.000	0.993	0.007
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.993	0.007
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.993	0.007
T47.7 Emetics	0.000	0.993	0.007
T47.6 Antidiarrhoeal drugs	0.000	0.993	0.007
T47.5 Digestants	0.000	0.993	0.007
T47.4 Other laxatives	0.000	0.993	0.007
T47.3 Saline and osmotic laxatives	0.000	0.993	0.007
T47.2 Stimulant laxatives	0.000	0.993	0.007
T47.0 Histamine H(2)-receptor antagonists	0.000	0.993	0.007
T50.4 Drugs affecting uric acid metabolism	0.000	0.993	0.007
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.000	0.993	0.007
T40.6 Other and unspecified narcotics	0.000	0.993	0.007
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.993	0.007
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.993	0.007
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.993	0.007
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.993	0.007
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.993	0.007
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.993	0.007
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.993	0.007
T44.0 Anticholinesterase agents	0.000	0.993	0.007
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.993	0.006
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.993	0.006
T37.5 Antiviral drugs	0.000	0.993	0.006
T37.4 Anthelminthics	0.000	0.993	0.006
T37.3 Other antiprotozoal drugs	0.000	0.993	0.006
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.993	0.006
T37.1 Antimycobacterial drugs	0.000	0.993	0.006
T37.0 Sulphonamides	0.000	0.993	0.006
T41.5 Therapeutic gases	0.000	0.993	0.006
T41.4 Anaesthetic, unspecified	0.000	0.993	0.006
T41.3 Local anaesthetics	0.000	0.993	0.006
T41.2 Other and unspecified general anaesthetics	0.000	0.993	0.006
T41.1 Intravenous anaesthetics	0.000	0.993	0.006
T41.0 Inhaled anaesthetics	0.000	0.993	0.006
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.993	0.006
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.993	0.006
T48.5 Anti-common-cold drugs	0.000	0.993	0.006
T48.4 Expectorants	0.000	0.993	0.006
T48.3 Antitussives	0.000	0.993	0.006
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.993	0.006
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.993	0.006
T48.0 Oxytocic drugs	0.000	0.993	0.006
T49.9 Topical agent, unspecified	0.000	0.993	0.006
T49.8 Other topical agents	0.000	0.993	0.006
T49.7 Dental drugs, topically applied	0.000	0.993	0.006
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.993	0.006
T49.5 Ophthalmological drugs and preparations	0.000	0.993	0.006
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.993	0.006
T49.3 Emollients, demulcents and protectants	0.000	0.993	0.006
T49.2 Local astringents and local detergents	0.000	0.993	0.006
T49.1 Antipruritics	0.000	0.993	0.006
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.993	0.006
S06.61 Traumatic subarachnoid haemorrhage (with open intracranial wound)	0.000	0.993	0.006
C77.5 Intrapelvic lymph nodes	0.000	0.993	0.007
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.993	0.006
Z36.0 Antenatal screening for chromosomal anomalies	0.006	0.993	0.000
T43.6 Psychostimulants with abuse potential	0.000	0.994	0.006
E27.1 Primary adrenocortical insufficiency	0.006	0.994	0.000
T38.1 Thyroid hormones and substitutes	0.000	0.994	0.006
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.994	0.006
T45.8 Other primarily systemic and haematological agents	0.000	0.994	0.006
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.994	0.006
T45.6 Fibrinolysis-affecting drugs	0.000	0.994	0.006
T45.4 Iron and its compounds	0.000	0.994	0.006
T45.3 Enzymes, not elsewhere classified	0.000	0.994	0.006
T36.9 Systemic antibiotic, unspecified	0.000	0.994	0.006
T36.8 Other systemic antibiotics	0.000	0.994	0.006
T36.7 Antifungal antibiotics, systemically used	0.000	0.994	0.006
T36.6 Rifamycins	0.000	0.994	0.006
T36.5 Aminoglycosides	0.000	0.994	0.006
T36.4 Tetracyclines	0.000	0.994	0.006
T36.3 Macrolides	0.000	0.994	0.006
T36.2 Chloramphenicol group	0.000	0.994	0.006
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.994	0.006
T38.9 Other and unspecified hormone antagonists	0.000	0.994	0.006
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.994	0.006
T38.7 Androgens and anabolic congeners	0.000	0.994	0.006
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.994	0.006
T38.5 Other oestrogens and progestogens	0.000	0.994	0.006
T38.4 Oral contraceptives	0.000	0.994	0.006
T38.2 Antithyroid drugs	0.000	0.994	0.006
T38.0 Glucocorticoids and synthetic analogues	0.000	0.994	0.006
Y60.0 During surgical operation	0.006	0.994	0.000
M53.3 Sacrococcygeal disorders, not elsewhere classified	0.000	0.994	0.006
T45.2 Vitamins, not elsewhere classified	0.000	0.994	0.006
T39.0 Salicylates	0.000	0.994	0.006
F33 Recurrent depressive disorder	0.000	0.994	0.006
N36.8 Other specified disorders of urethra	0.006	0.994	0.000
S06 Intracranial injury	0.000	0.994	0.006
E27 Other disorders of adrenal gland	0.006	0.994	0.000
B37.0 Candidal stomatitis	0.000	0.994	0.006
N04 Nephrotic syndrome	0.005	0.995	0.000
E27.8 Other specified disorders of adrenal gland	0.005	0.995	0.000
T45.5 Anticoagulants	0.000	0.995	0.005
F30-F39 Mood [affective] disorders	0.000	0.995	0.005
T36.0 Penicillins	0.000	0.995	0.005
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.995	0.005
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.995	0.005
N36.3 Prolapsed urethral mucosa	0.005	0.995	0.000
N36 Other disorders of urethra	0.005	0.995	0.000
S06.2 Diffuse brain injury	0.000	0.995	0.005
Z39.1 Care and examination of lactating mother	0.000	0.995	0.005
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.000	0.995	0.005
N36.2 Urethral caruncle	0.005	0.995	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.995	0.005
S06.20 Diffuse brain injury (without open intracranial wound)	0.000	0.995	0.005
S06.0 Concussion	0.000	0.995	0.005
S06.5 Traumatic subdural haemorrhage	0.000	0.995	0.005
F30 Manic episode	0.000	0.995	0.005
E27.2 Addisonian crisis	0.005	0.995	0.000
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.000	0.995	0.005
M53.37 Sacrococcygeal disorders, not elsewhere classified-Lumbosac	0.000	0.995	0.004
M53.36 Sacrococcygeal disorders, not elsewhere classified-Lumbar	0.000	0.995	0.004
M53.35 Sacrococcygeal disorders, not elsewhere classified-Thoracol	0.000	0.995	0.004
M53.34 Sacrococcygeal disorders, not elsewhere classified-Thoracic	0.000	0.995	0.004
M53.33 Sacrococcygeal disorders, not elsewhere classified-Cervicot	0.000	0.995	0.004
M53.32 Sacrococcygeal disorders, not elsewhere classified-Cervical	0.000	0.995	0.004
M53.31 Sacrococcygeal disorders, not elsewhere classified-Occipit-	0.000	0.995	0.004
M53.30 Sacrococcygeal disorders, not elsewhere classified-Mult sit	0.000	0.995	0.004
Z39.0 Care and examination immediately after delivery	0.000	0.995	0.005
N04.1 Focal and segmental glomerular lesions	0.004	0.996	0.000
N04.2 Diffuse membranous glomerulonephritis	0.004	0.996	0.000
M53.39 Sacrococcygeal disorders, not elsewhere classified-Site uns	0.000	0.996	0.004
F33.8 Other recurrent depressive disorders	0.000	0.996	0.004
F33.4 Recurrent depressive disorder, currently in remission	0.000	0.996	0.004
E27.4 Other and unspecified adrenocortical insufficiency	0.004	0.996	0.000
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.000	0.996	0.004
S06.9 Intracranial injury, unspecified	0.000	0.996	0.004
F33.0 Recurrent depressive disorder, current episode mild	0.000	0.996	0.004
S06.00 Concussion (without open intracranial wound)	0.000	0.996	0.004
S06.7 Intracranial injury with prolonged coma	0.000	0.996	0.004
S06.1 Traumatic cerebral oedema	0.000	0.996	0.004
E27.5 Adrenomedullary hyperfunction	0.004	0.996	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.004	0.996	0.000
E27.0 Other adrenocortical overactivity	0.004	0.996	0.000
F30.9 Manic episode, unspecified	0.000	0.996	0.004
N36.9 Urethral disorder, unspecified	0.004	0.996	0.000
S06.50 Traumatic subdural haemorrhage (without open intracranial wound)	0.000	0.996	0.004
N04.8 Other	0.004	0.996	0.000
N04.7 Diffuse crescentic glomerulonephritis	0.004	0.996	0.000
N04.6 Dense deposit disease	0.004	0.996	0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.004	0.996	0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.004	0.996	0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.004	0.996	0.000
N04.0 Minor glomerular abnormality	0.004	0.996	0.000
E27.9 Disorder of adrenal gland, unspecified	0.004	0.996	0.000
Z39 Postpartum care and examination	0.000	0.996	0.004
F60.3 Emotionally unstable personality disorder	0.000	0.996	0.004
F38 Other mood [affective] disorders	0.000	0.996	0.004
F34 Persistent mood [affective] disorders	0.000	0.996	0.004
F30.2 Mania with psychotic symptoms	0.000	0.996	0.004
S06.21 Diffuse brain injury (with open intracranial wound)	0.000	0.996	0.004
S06.8 Other intracranial injuries	0.000	0.996	0.004
N36.0 Urethral fistula	0.004	0.996	0.000
J38.7 Other diseases of larynx	0.000	0.996	0.004
S06.4 Epidural haemorrhage	0.000	0.996	0.004
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.000	0.996	0.004
S06.01 Concussion (with open intracranial wound)	0.000	0.996	0.004
F33.1 Recurrent depressive disorder, current episode moderate	0.000	0.996	0.004
S06.3 Focal brain injury	0.000	0.996	0.004
S06.51 Traumatic subdural haemorrhage (with open intracranial wound)	0.000	0.996	0.004
C77.9 Lymph node, unspecified	0.000	0.996	0.004
F30.8 Other manic episodes	0.000	0.996	0.004
F30.1 Mania without psychotic symptoms	0.000	0.996	0.004
N36.1 Urethral diverticulum	0.003	0.996	0.000
Z39.2 Routine postpartum follow-up	0.000	0.996	0.003
S06.90 Intracranial injury, unspecified (without open intracranial wound)	0.000	0.996	0.003
N05 Unspecified nephritic syndrome	0.003	0.996	0.000
D17.1 Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk	0.003	0.997	0.000
F30.0 Hypomania	0.000	0.997	0.003
S22.00 Fracture of thoracic vertebra (closed)	0.003	0.997	0.000
F52.2 Failure of genital response	0.000	0.997	0.003
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care	0.003	0.997	0.000
S06.91 Intracranial injury, unspecified (with open intracranial wound)	0.000	0.997	0.003
N00-N08 Glomerular diseases	0.003	0.997	0.000
S06.11 Traumatic cerebral oedema (with open intracranial wound)	0.000	0.997	0.003
S06.10 Traumatic cerebral oedema (without open intracranial wound)	0.000	0.997	0.003
S06.71 Intracranial injury with prolonged coma (with open intracranial wound)	0.000	0.997	0.003
S06.70 Intracranial injury with prolonged coma (without open intracranial wound)	0.000	0.997	0.003
N05.1 Focal and segmental glomerular lesions	0.003	0.997	0.000
F60 Specific personality disorders	0.000	0.997	0.003
F34.9 Persistent mood [affective] disorder, unspecified	0.000	0.997	0.003
F34.8 Other persistent mood [affective] disorders	0.000	0.997	0.003
F34.0 Cyclothymia	0.000	0.997	0.003
F38.8 Other specified mood [affective] disorders	0.000	0.997	0.003
F38.1 Other recurrent mood [affective] disorders	0.000	0.997	0.003
F38.0 Other single mood [affective] disorders	0.000	0.997	0.003
F34.1 Dysthymia	0.000	0.997	0.003
E21.3 Hyperparathyroidism, unspecified	0.003	0.997	0.000
S02.30 Fracture of orbital floor (closed)	0.000	0.997	0.003
Z45.2 Adjustment and management of vascular access device	0.000	0.997	0.003
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.000	0.997	0.003
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.000	0.997	0.003
D36.7 Other specified sites	0.000	0.997	0.003
S06.81 Other intracranial injuries (with open intracranial wound)	0.000	0.997	0.003
F39 Unspecified mood [affective] disorder	0.000	0.997	0.003
N05.8 Other	0.003	0.997	0.000
Q63.0 Accessory kidney	0.000	0.997	0.003
S06.41 Epidural haemorrhage (with open intracranial wound)	0.000	0.997	0.003
N05.9 Unspecified	0.003	0.997	0.000
S06.31 Focal brain injury (with open intracranial wound)	0.000	0.997	0.003
E24 Cushing's syndrome	0.003	0.997	0.000
E20-E35 Disorders of other endocrine glands	0.003	0.997	0.000
C78.2 Secondary malignant neoplasm of pleura	0.000	0.997	0.003
N02 Recurrent and persistent haematuria	0.003	0.997	0.000
C77.8 Lymph nodes of multiple regions	0.000	0.997	0.003
E20.9 Hypoparathyroidism, unspecified	0.003	0.997	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.003	0.997	0.000
C77.4 Inguinal and lower limb lymph nodes	0.000	0.997	0.003
C55 Malignant neoplasm of uterus, part unspecified	0.000	0.997	0.003
E20 Hypoparathyroidism	0.003	0.997	0.000
K60.2 Anal fissure, unspecified	0.003	0.997	0.000
N02.9 Unspecified	0.003	0.997	0.000
N05.2 Diffuse membranous glomerulonephritis	0.003	0.997	0.000
F60.9 Personality disorder, unspecified	0.000	0.997	0.003
N05.7 Diffuse crescentic glomerulonephritis	0.003	0.997	0.000
N05.6 Dense deposit disease	0.003	0.997	0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.997	0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.003	0.997	0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.997	0.000
N05.0 Minor glomerular abnormality	0.003	0.997	0.000
Y60.5 During heart catheterisation	0.003	0.997	0.000
M53 Other dorsopathies, not elsewhere classified	0.000	0.997	0.003
Y60.9 During unspecified surgical and medical care	0.003	0.997	0.000
Y60.8 During other surgical and medical care	0.003	0.997	0.000
Y60.7 During administration of enema	0.003	0.997	0.000
Y60.6 During aspiration, puncture and other catheterisation	0.003	0.997	0.000
Y60.3 During injection or immunisation	0.003	0.997	0.000
Y60.2 During kidney dialysis or other perfusion	0.003	0.997	0.000
Y60.1 During infusion or transfusion	0.003	0.997	0.000
E24.9 Cushing's syndrome, unspecified	0.003	0.997	0.000
I70.2 Atherosclerosis of arteries of the extremities	0.000	0.997	0.003
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.003	0.997	0.000
Y60.4 During endoscopic examination	0.003	0.997	0.000
N07 Hereditary nephropathy, not elsewhere classified	0.003	0.997	0.000
N06 Isolated proteinuria with specified morphological lesion	0.003	0.997	0.000
N01 Rapidly progressive nephritic syndrome	0.003	0.997	0.000
N00 Acute nephritic syndrome	0.003	0.997	0.000
E24.0 Pituitary-dependent Cushing's disease	0.003	0.997	0.000
N08 Glomerular disorders in diseases classified elsewhere	0.003	0.997	0.000
F52 Sexual dysfunction, not caused by organic disorder or disease	0.000	0.997	0.003
C54.1 Endometrium	0.000	0.997	0.003
N31.2 Flaccid neuropathic bladder, not elsewhere classified	0.000	0.997	0.003
S06.80 Other intracranial injuries (without open intracranial wound)	0.000	0.997	0.002
D41.4 Bladder	0.003	0.997	0.000
F60.8 Other specific personality disorders	0.000	0.997	0.002
F60.5 Anankastic personality disorder	0.000	0.997	0.002
F60.4 Histrionic personality disorder	0.000	0.997	0.002
F60.2 Dissocial personality disorder	0.000	0.997	0.002
F60.1 Schizoid personality disorder	0.000	0.997	0.002
F60.0 Paranoid personality disorder	0.000	0.997	0.002
F60.6 Anxious [avoidant] personality disorder	0.000	0.997	0.002
I45.9 Conduction disorder, unspecified	0.003	0.997	0.000
W29.9 Unspecified place	0.003	0.997	0.000
J95.8 Other postprocedural respiratory disorders	0.000	0.997	0.003
K65.0 Acute peritonitis	0.000	0.997	0.003
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.000	0.997	0.003
E28 Ovarian dysfunction	0.002	0.997	0.000
S06.40 Epidural haemorrhage (without open intracranial wound)	0.000	0.998	0.002
F60-F69 Disorders of adult personality and behaviour	0.000	0.998	0.002
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.000	0.998	0.002
F60.7 Dependent personality disorder	0.000	0.998	0.002
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.002	0.998	0.000
E28.3 Primary ovarian failure	0.002	0.998	0.000
E24.8 Other Cushing's syndrome	0.002	0.998	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.002	0.998	0.000
E24.3 Ectopic ACTH syndrome	0.002	0.998	0.000
E24.2 Drug-induced Cushing's syndrome	0.002	0.998	0.000
E24.1 Nelson's syndrome	0.002	0.998	0.000
R45.1 Restlessness and agitation	0.000	0.998	0.002
E35 Disorders of endocrine glands in diseases classified elsewhere	0.002	0.998	0.000
E32 Diseases of thymus	0.002	0.998	0.000
E31 Polyglandular dysfunction	0.002	0.998	0.000
E30 Disorders of puberty, not elsewhere classified	0.002	0.998	0.000
E25 Adrenogenital disorders	0.002	0.998	0.000
S06.30 Focal brain injury (without open intracranial wound)	0.000	0.998	0.002
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.000	0.998	0.002
E21.5 Disorder of parathyroid gland, unspecified	0.002	0.998	0.000
E21.4 Other specified disorders of parathyroid gland	0.002	0.998	0.000
E21.2 Other hyperparathyroidism	0.002	0.998	0.000
N02.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N02.6 Dense deposit disease	0.002	0.998	0.000
N02.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N02.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N02.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N02.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N02.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N02.0 Minor glomerular abnormality	0.002	0.998	0.000
Q63 Other congenital malformations of kidney	0.000	0.998	0.002
M41.99 Scoliosis, unspecified (Site unspecified)	0.000	0.998	0.002
E20.8 Other hypoparathyroidism	0.002	0.998	0.000
E20.1 Pseudohypoparathyroidism	0.002	0.998	0.000
E20.0 Idiopathic hypoparathyroidism	0.002	0.998	0.000
S02.3 Fracture of orbital floor	0.000	0.998	0.002
S82.80 Fractures of other parts of lower leg (closed)	0.000	0.998	0.002
M53.9 Dorsopathy, unspecified	0.000	0.998	0.002
M53.8 Other specified dorsopathies	0.000	0.998	0.002
M53.2 Spinal instabilities	0.000	0.998	0.002
M53.1 Cervicobrachial syndrome	0.000	0.998	0.002
M53.0 Cervicocranial syndrome	0.000	0.998	0.002
C54 Malignant neoplasm of corpus uteri	0.000	0.998	0.002
C78.1 Secondary malignant neoplasm of mediastinum	0.000	0.998	0.002
R30.9 Painful micturition, unspecified	0.002	0.998	0.000
I70.21 Atherosclerosis of arteries of extremities (with gangrene)	0.000	0.998	0.002
K60.1 Chronic anal fissure	0.002	0.998	0.000
N00.9 Unspecified	0.002	0.998	0.000
N00.8 Other	0.002	0.998	0.000
N00.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N00.6 Dense deposit disease	0.002	0.998	0.000
N00.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N00.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N00.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N00.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N00.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N00.0 Minor glomerular abnormality	0.002	0.998	0.000
N01.9 Unspecified	0.002	0.998	0.000
N01.8 Other	0.002	0.998	0.000
N01.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N01.6 Dense deposit disease	0.002	0.998	0.000
N01.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N01.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N01.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N01.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N01.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N01.0 Minor glomerular abnormality	0.002	0.998	0.000
N06.9 Unspecified	0.002	0.998	0.000
N06.8 Other	0.002	0.998	0.000
N06.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N06.6 Dense deposit disease	0.002	0.998	0.000
N06.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N06.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N06.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N06.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N06.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N06.0 Minor glomerular abnormality	0.002	0.998	0.000
N07.9 Unspecified	0.002	0.998	0.000
N07.8 Other	0.002	0.998	0.000
N07.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N07.6 Dense deposit disease	0.002	0.998	0.000
N07.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N07.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N07.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N07.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N07.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N07.0 Minor glomerular abnormality	0.002	0.998	0.000
F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease	0.000	0.998	0.002
F52.8 Other sexual dysfunction, not caused by organic disorder or disease	0.000	0.998	0.002
F52.7 Excessive sexual drive	0.000	0.998	0.002
F52.6 Nonorganic dyspareunia	0.000	0.998	0.002
F52.5 Nonorganic vaginismus	0.000	0.998	0.002
F52.4 Premature ejaculation	0.000	0.998	0.002
F52.3 Orgasmic dysfunction	0.000	0.998	0.002
F52.1 Sexual aversion and lack of sexual enjoyment	0.000	0.998	0.002
F52.0 Lack or loss of sexual desire	0.000	0.998	0.002
N08.8 Glomerular disorders in other diseases classified elsewhere	0.002	0.998	0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism	0.002	0.998	0.000
N08.1 Glomerular disorders in neoplastic diseases	0.002	0.998	0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
Q63.1 Lobulated, fused and horseshoe kidney	0.000	0.998	0.002
E22 Hyperfunction of pituitary gland	0.002	0.998	0.000
D34 Benign neoplasm of thyroid gland	0.000	0.998	0.002
O69.2 Labour and delivery complicated by other cord entanglement	0.000	0.998	0.002
F69 Unspecified disorder of adult personality and behaviour	0.000	0.998	0.002
K74.3 Primary biliary cirrhosis	0.000	0.998	0.002
K50-K52 Noninfective enteritis and colitis	0.002	0.998	0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.000	0.998	0.002
C78.4 Secondary malignant neoplasm of small intestine	0.000	0.998	0.002
K22.4 Dyskinesia of oesophagus	0.002	0.998	0.000
E34 Other endocrine disorders	0.002	0.998	0.000
E26 Hyperaldosteronism	0.002	0.998	0.001
F43.2 Adjustment disorders	0.000	0.998	0.002
C92.1 Chronic myeloid leukaemia	0.000	0.998	0.002
F64 Gender identity disorders	0.000	0.998	0.002
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.000	0.998	0.002
E28.9 Ovarian dysfunction, unspecified	0.002	0.998	0.000
E28.8 Other ovarian dysfunction	0.002	0.998	0.000
E28.1 Androgen excess	0.002	0.998	0.000
E28.0 Oestrogen excess	0.002	0.998	0.000
Q66.9 Congenital deformity of feet, unspecified	0.002	0.998	0.000
Q66.8 Other congenital deformities of feet	0.002	0.998	0.000
F68 Other disorders of adult personality and behaviour	0.000	0.998	0.002
F66 Psychological and behavioural disorders associated with sexual development and orientation	0.000	0.998	0.002
F65 Disorders of sexual preference	0.000	0.998	0.002
F63 Habit and impulse disorders	0.000	0.998	0.002
F62 Enduring personality changes, not attributable to brain damage and disease	0.000	0.998	0.002
F61 Mixed and other personality disorders	0.000	0.998	0.002
M23.35 Other meniscus derangements (Posterior horn of lateral meniscus)	0.002	0.998	0.000
C54.9 Corpus uteri, unspecified	0.000	0.998	0.002
F43.9 Reaction to severe stress, unspecified	0.000	0.998	0.002
Q61.2 Polycystic kidney, adult type	0.000	0.998	0.002
C56 Malignant neoplasm of ovary	0.000	0.998	0.002
F43 Reaction to severe stress, and adjustment disorders	0.000	0.998	0.002
E25.9 Adrenogenital disorder, unspecified	0.002	0.998	0.000
E25.8 Other adrenogenital disorders	0.002	0.998	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.002	0.998	0.000
E30.9 Disorder of puberty, unspecified	0.002	0.998	0.000
E30.8 Other disorders of puberty	0.002	0.998	0.000
E30.1 Precocious puberty	0.002	0.998	0.000
E30.0 Delayed puberty	0.002	0.998	0.000
E31.9 Polyglandular dysfunction, unspecified	0.002	0.998	0.000
E31.8 Other polyglandular dysfunction	0.002	0.998	0.000
E31.1 Polyglandular hyperfunction	0.002	0.998	0.000
E31.0 Autoimmune polyglandular failure	0.002	0.998	0.000
E32.9 Disease of thymus, unspecified	0.002	0.998	0.000
E32.8 Other diseases of thymus	0.002	0.998	0.000
E32.1 Abscess of thymus	0.002	0.998	0.000
E32.0 Persistent hyperplasia of thymus	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations